{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:18:46Z","timestamp":1759479526833},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,9,29]],"date-time":"2006-09-29T00:00:00Z","timestamp":1159488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,9,29]],"date-time":"2006-09-29T00:00:00Z","timestamp":1159488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/s11255-006-9075-8","type":"journal-article","created":{"date-parts":[[2006,9,28]],"date-time":"2006-09-28T08:19:23Z","timestamp":1159431563000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hepatitis C inflection in dialysis patients: a link to poor clinical outcome?"],"prefix":"10.1007","volume":"39","author":[{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric S.","family":"Daar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor E.","family":"Eysselein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loren G.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,9,29]]},"reference":[{"key":"9075_CR1","unstructured":"Recommendations and reports (1998) Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 47"},{"key":"9075_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0272-6386(03)00828-X","volume":"42","author":"CM Meyers","year":"2003","unstructured":"Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH (2003) Hepatitis C and renal disease: an update. Am J Kidney Dis 42:631\u2013657","journal-title":"Am J Kidney Dis"},{"key":"9075_CR3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1034\/j.1600-6143.2001.10213.x","volume":"1","author":"DS Batty Jr","year":"2001","unstructured":"Batty DS Jr, Swanson SJ, Kirk AD, Ko CW, Agodoa LY, Abbott KC (2001) Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant 1:179\u2013184","journal-title":"Am J Transplant"},{"key":"9075_CR4","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1086\/315869","volume":"182","author":"PM Schneeberger","year":"2000","unstructured":"Schneeberger PM, Keur I, van Loon AM, Mortier D, de Coul KO, van Haperen AV, Sanna R, van Der Heijden TG, van Den Hoven H, van Hamersvelt HW, Quint W, van Doorn LJ (2000) The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: a nationwide prospective study. J Infect Dis 182:1291\u20131299","journal-title":"J Infect Dis"},{"key":"9075_CR5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0272-6386(95)90100-0","volume":"25","author":"B Dussol","year":"1995","unstructured":"Dussol B, Berthezene P, Brunet P, Roubicek C, Berland Y (1995) Hepatitis C virus infection among chronic dialysis patients in the south of France: a collaborative study. Am J Kidney Dis 25:399\u2013404","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 1","key":"9075_CR6","first-page":"S1","volume":"45","author":"United States renal data system","year":"2005","unstructured":"United States renal data system (2005) Excerpts from the USRDS 2004 Annual Data Report. Am J Kid Dis 45(Suppl 1):S1\u2013S280","journal-title":"Am J Kid Dis"},{"key":"9075_CR7","unstructured":"United States renal data system (2002) US Department of public health and human services, public health service, National institutes of health, Bethesda"},{"key":"9075_CR8","doi-asserted-by":"crossref","unstructured":"Collins AJ, Couser WG, Dirks JH, Kopple JD, Reiser T, Riella MC, Robinson S, Shah SV, Wilson A (2006) World kidney day: an idea whose time has come. J\u2423Am Soc Nephrol","DOI":"10.1038\/sj.ki.5000250"},{"key":"9075_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11255-004-0012-4","volume":"37","author":"K Kalantar-Zadeh","year":"2005","unstructured":"Kalantar-Zadeh K, Unruh M (2005) Health related quality of life in patients with chronic kidney disease. Int Urol Nephrol 37:367\u2013378","journal-title":"Int Urol Nephrol"},{"key":"9075_CR10","unstructured":"Morbidity and mortality of dialysis (1993) NIH consens statement 11:1\u201333"},{"key":"9075_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000082012","volume":"23","author":"K Kalantar-Zadeh","year":"2005","unstructured":"Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, Wu DY (2005) Reverse epidemiology: a spurious hypothesis or a hardcore reality? Blood Purif 23:57\u201363","journal-title":"Blood Purif"},{"key":"9075_CR12","unstructured":"United States renal data system (2003) USRD 2003 Annual data report; atlas of end stage renal diseases in the United States. National institute of health, National institute of diabetes and digestive and kidney diseases. Bethesda, Maryland"},{"key":"9075_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1056\/NEJMoa043545","volume":"353","author":"C Wanner","year":"2005","unstructured":"Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353:238\u2013248","journal-title":"N Engl J Med"},{"key":"9075_CR14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/01.ASN.0000110181.64655.6C","volume":"15","author":"EM Wrone","year":"2004","unstructured":"Wrone EM, Hornberger JM, Zehnder JL, McCann LM, Coplon NS, Fortmann SP (2004) Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J Am Soc Nephrol 15:420\u2013426","journal-title":"J Am Soc Nephrol"},{"key":"9075_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/01.ASN.0000107564.60018.51","volume":"15","author":"K Kalantar-Zadeh","year":"2004","unstructured":"Kalantar-Zadeh K, Block G, Humphreys MH, McAllister CJ, Kopple JD (2004) A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol 15:442\u2013453","journal-title":"J Am Soc Nephrol"},{"key":"9075_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ndt\/gfh447","volume":"20","author":"ME Suliman","year":"2004","unstructured":"Suliman ME, Barany P, Kalantar-Zadeh K, Lindholm B, Stenvinkel P (2004) Homocysteine in uraemia\u2014a puzzling and conflicting story. Nephrol Dial Transplant 20:16\u201321","journal-title":"Nephrol Dial Transplant"},{"key":"9075_CR17","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1056\/NEJMoa021583","volume":"347","author":"G Eknoyan","year":"2002","unstructured":"Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010\u20132019","journal-title":"N Engl J Med"},{"key":"9075_CR18","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.V1351307","volume":"13","author":"R Paniagua","year":"2002","unstructured":"Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S (2002) Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13:1307\u20131320","journal-title":"J Am Soc Nephrol"},{"key":"9075_CR19","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S0272-6386(03)00915-6","volume":"42","author":"K Kalantar-Zadeh","year":"2003","unstructured":"Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD (2003) Malnutrition\u2013inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 42:864\u2013881","journal-title":"Am J Kidney Dis"},{"key":"9075_CR20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1053\/ajkd.2001.29250","volume":"38","author":"K Kalantar-Zadeh","year":"2001","unstructured":"Kalantar-Zadeh K, Kopple JD (2001) Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 38:1343\u20131350","journal-title":"Am J Kidney Dis"},{"key":"9075_CR21","first-page":"641","volume":"104","author":"J Bergstrom","year":"2000","unstructured":"Bergstrom J (2000) Inflammation, malnutrition, cardiovascular disease and mortality in end-stage renal disease. Pol Arch Med Wewn 104:641\u2013643","journal-title":"Pol Arch Med Wewn"},{"issue":"Suppl 1","key":"9075_CR22","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1681\/ASN.V13suppl_1s28","volume":"13","author":"AR Qureshi","year":"2002","unstructured":"Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimburger O, Lindholm B, Bergstrom J (2002) Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13(Suppl 1):S28\u2013S36","journal-title":"J Am Soc Nephrol"},{"key":"9075_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000046932","volume":"19","author":"P Stenvinkel","year":"2001","unstructured":"Stenvinkel P (2001) Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif 19:143\u2013151","journal-title":"Blood Purif"},{"issue":"Suppl 3","key":"9075_CR24","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1177\/089686080102103S27","volume":"21","author":"P Stenvinkel","year":"2001","unstructured":"Stenvinkel P, Chung SH, Heimburger O, Lindholm B (2001) Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients. Perit Dial Int 21(Suppl 3):S157\u2013S162","journal-title":"Perit Dial Int"},{"key":"9075_CR25","first-page":"845","volume":"31","author":"O Ifudu","year":"2002","unstructured":"Ifudu O, Uribarri J, Rajwani I, Vlacich V, Reydel K, Delosreyes G, Friedman E (2002) Low hematocrit may connote a malnutrition\u2013inflammation syndrome in hemodialysis patients. Dialysis Transplant 31:845\u2013878","journal-title":"Dialysis Transplant"},{"key":"9075_CR26","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/ajcn\/65.5.1544","volume":"65","author":"JD Kopple","year":"1997","unstructured":"Kopple JD (1997) McCollum Award Lecture, 1996: protein-energy malnutrition in maintenance dialysis patients. Am J Clin Nutr 65:1544\u20131557","journal-title":"Am J Clin Nutr"},{"key":"9075_CR27","doi-asserted-by":"crossref","first-page":"247S","DOI":"10.1093\/jn\/129.1.247S","volume":"129","author":"JD Kopple","year":"1999","unstructured":"Kopple JD (1999) Pathophysiology of protein-energy wasting in chronic renal failure. J Nutr 129:247S\u2013251S","journal-title":"J Nutr"},{"key":"9075_CR28","unstructured":"Mehrotra R, Kopple J (2003) Causes of protein-\tenergy malnutrition in chronic renal failure. In: Kopple J, Massry S (eds) Nutritional management of renal disease, 2nd edn. Williams & Wilkins, Lippincott, Philadelphia"},{"key":"9075_CR29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1046\/j.1523-1755.1998.00812.x","volume":"53","author":"AR Qureshi","year":"1998","unstructured":"Qureshi AR, Alvestrand A, Danielsson A, Divino-Filho JC, Gutierrez A, Lindholm B, Bergstrom J (1998) Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 53:773\u2013782","journal-title":"Kidney Int"},{"key":"9075_CR30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0272-6386(95)90178-7","volume":"26","author":"J Bergstrom","year":"1995","unstructured":"Bergstrom J (1995) Why are dialysis patients malnourished? Am J Kidney Dis 26:229\u2013241","journal-title":"Am J Kidney Dis"},{"key":"9075_CR31","unstructured":"Kalantar-Zadeh K, Kopple J Inflammation in renal failure, in UpToDate (since Oct 2002), edited by Rose B, Wellesley, MA, UpToDate, Inc, 2003"},{"key":"9075_CR32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ajcn\/80.2.299","volume":"80","author":"K Kalantar-Zadeh","year":"2004","unstructured":"Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD (2004) Appetite and inflammation, nutrition, anemia and clinical outcome in hemodialysis patients. Am J Clin Nutr 80:299\u2013307","journal-title":"Am J Clin Nutr"},{"key":"9075_CR33","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMoa021993","volume":"347","author":"PM Ridker","year":"2002","unstructured":"Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557\u20131565","journal-title":"N Engl J Med"},{"key":"9075_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa042378","volume":"352","author":"PM Ridker","year":"2005","unstructured":"Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E (2005) C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352:20\u201328","journal-title":"N Engl J Med"},{"key":"9075_CR35","unstructured":"Kalantar-Zadeh K, Kopple J (2005) Inflammation in renal failure, in UpToDate (since Oct 2002), edited by Rose B, Wellesley, MA, UpToDate, Inc"},{"key":"9075_CR36","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/01.mco.0000172578.56396.9e","volume":"8","author":"K Kalantar-Zadeh","year":"2005","unstructured":"Kalantar-Zadeh K, Stenvinkel P, Bross R, Khawar OS, Rammohan M, Colman S, Benner D (2005) Kidney insufficiency and nutrient-based modulation of inflammation. Curr Opin Clin Nutr Metab Care 8:388\u2013396","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"9075_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1525-139X.2005.00074.x","volume":"18","author":"K Kalantar-Zadeh","year":"2005","unstructured":"Kalantar-Zadeh K (2005) Recent advances in understanding the malnutrition\u2013inflammation\u2013Cachexia syndrome in chronic kidney disease patients: what is next? Semin Dial 18:365\u2013369","journal-title":"Semin Dial"},{"key":"9075_CR38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.arrt.2003.08.008","volume":"10","author":"K Kalantar-Zadeh","year":"2003","unstructured":"Kalantar-Zadeh K, Stenvinkel P, Pillon L, Kopple JD (2003) Inflammation and nutrition in renal insufficiency. Adv Ren Replace Ther 10:155\u2013169","journal-title":"Adv Ren Replace Ther"},{"key":"9075_CR39","doi-asserted-by":"crossref","unstructured":"Stenvinkel P, Barany P, Heimburger O, Pecoits-Filho R, Lindholm B (2002) Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6? Kidney Int Suppl:103\u2013108","DOI":"10.1046\/j.1523-1755.61.s80.19.x"},{"key":"9075_CR40","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","volume":"55","author":"J Zimmermann","year":"1999","unstructured":"Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648\u2013658","journal-title":"Kidney Int"},{"key":"9075_CR41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/ajkd.1998.v32.pm9669431","volume":"32","author":"RM Bologa","year":"1998","unstructured":"Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL (1998) Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32:107\u2013114","journal-title":"Am J Kidney Dis"},{"key":"9075_CR42","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/ndt\/gfh941","volume":"20","author":"K Kalantar-Zadeh","year":"2005","unstructured":"Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, Greenland S (2005) Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 20:1880\u20131889","journal-title":"Nephrol Dial Transplant"},{"key":"9075_CR43","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1053\/ajkd.2002.35679","volume":"40","author":"S Beddhu","year":"2002","unstructured":"Beddhu S, Kaysen GA, Yan G, Sarnak M, Agodoa L, Ornt D, Cheung AK (2002) Association of serum albumin and atherosclerosis in chronic hemodialysis patients. Am J Kidney Dis 40:721\u2013727","journal-title":"Am J Kidney Dis"},{"key":"9075_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.med.52.1.289","volume":"52","author":"AE Becker","year":"2001","unstructured":"Becker AE, de Boer OJ, van Der Wal AC (2001) The role of inflammation and infection in coronary artery disease. Annu Rev Med 52:289\u2013297","journal-title":"Annu Rev Med"},{"key":"9075_CR45","first-page":"1010","volume-title":"Braunwald: heart disease: a textbook of cardiovascular medicine","author":"N Kaplan","year":"2001","unstructured":"Kaplan N (2001) Risk factor for atherosclerotic disease. In: Braunwald EZD, Libby P (eds) Braunwald: heart disease: a textbook of cardiovascular medicine. W. B. Saunders Company, Philadelphia, PA, pp 1010\u20131039"},{"key":"9075_CR46","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1046\/j.1523-1755.2001.00998.x","volume":"60","author":"D Mezzano","year":"2001","unstructured":"Mezzano D, Pais EO, Aranda E, Panes O, Downey P, Ortiz M, Tagle R, Gonzalez F, Quiroga T, Caceres MS, Leighton F, Pereira J (2001) Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 60:1844\u20131850","journal-title":"Kidney Int"},{"key":"9075_CR47","doi-asserted-by":"crossref","unstructured":"Kalantar-Zadeh K, Abbott KC, Kronenberg F, Anker SD, Horwich TB, Fonarow GC (2006) Epidemiology of dialysis patients and heart failure patients; special review article for the 25th anniversary of the Seminars in Nephrology. Semin Nephrol, Jan 2006 (in press)","DOI":"10.1016\/j.semnephrol.2005.09.005"},{"key":"9075_CR48","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1056\/NEJMoa011232","volume":"345","author":"E Jaeckel","year":"2001","unstructured":"Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, Pastore G, Dietrich M, Trautwein C, Manns MP (2001) Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 345:1452\u20131457","journal-title":"N Engl J Med"},{"key":"9075_CR49","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/j.1365-2036.2004.02290.x","volume":"20","author":"F Fabrizi","year":"2004","unstructured":"Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G (2004) Meta-analysis: effect of hepatitis C virus infection on mortality in dialysis. Aliment Pharmacol Ther 20:1271\u20131277","journal-title":"Aliment Pharmacol Ther"},{"key":"9075_CR50","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1046\/j.1525-139x.2000.00108.x","volume":"13","author":"SN Natov","year":"2000","unstructured":"Natov SN, Pereira BJ (2000) Routine serologic testing for hepatitis C virus infection should be instituted among dialysis patients. Semin Dial 13:393\u2013398","journal-title":"Semin Dial"},{"key":"9075_CR51","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1093\/ndt\/gfh895","volume":"20","author":"K Kalantar-Zadeh","year":"2005","unstructured":"Kalantar-Zadeh K, McAllister CJ, Miller LG (2005) Clinical characteristics and mortality in hepatitis C-positive haemo dialysis patients: a population based study. Nephrol Dial Transplant 20:1662\u20131669","journal-title":"Nephrol Dial Transplant"},{"key":"9075_CR52","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1111\/j.1523-1755.2004.00649.x","volume":"65","author":"RB Fissell","year":"2004","unstructured":"Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young EW (2004) Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 65:2335\u20132342","journal-title":"Kidney Int"},{"key":"9075_CR53","doi-asserted-by":"crossref","first-page":"B1","DOI":"10.1053\/j.ajkd.2005.10.015","volume":"47","author":"K Kalantar-Zadeh","year":"2006","unstructured":"Kalantar-Zadeh K, McAllister CJ, Kilpatrick RD, Miller LG, Daar ES, Gjertson DW, Kopple JD, Greenland S (2006) Dialysis vintage and risk of hepatitis C virus infection. Am J Kid Dis 47:B1\u2013B18 (abstract #72, NKF Spring Clinical Meetings April 19\u201323, 2006, Chicago, IL), 2006 [abstract]","journal-title":"Am J Kid Dis"},{"key":"9075_CR54","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/01.mcg.0000135372.10846.2a","volume":"38","author":"ZM Younossi","year":"2004","unstructured":"Younossi ZM, McCullough AJ, Ong JP, Barnes DS, Post A, Tavill A, Bringman D, Martin LM, Assmann J, Gramlich T, Mullen KD, O\u2019Shea R, Carey WD, Ferguson R (2004) Obesity and non-alcoholic fatty liver disease in chronic hepatitis C. J Clin Gastroenterol 38:705\u2013709","journal-title":"J Clin Gastroenterol"},{"key":"9075_CR55","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1046\/j.1463-1326.2003.00256.x","volume":"5","author":"F Friedenberg","year":"2003","unstructured":"Friedenberg F, Pungpapong S, Zaeri N, Braitman LE (2003) The impact of diabetes and obesity on liver histology in patients with hepatitis C. Diabetes Obes Metab 5:150\u2013155","journal-title":"Diabetes Obes Metab"},{"key":"9075_CR56","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1111\/j.1572-0241.2002.05995.x","volume":"97","author":"V Ortiz","year":"2002","unstructured":"Ortiz V, Berenguer M, Rayon JM, Carrasco D, Berenguer J (2002) Contribution of obesity to hepatitis C-related fibrosis progression. Am J Gastroenterol 97:2408\u20132414","journal-title":"Am J Gastroenterol"},{"key":"9075_CR57","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1053\/j.ajkd.2005.05.020","volume":"46","author":"K Kalantar-Zadeh","year":"2005","unstructured":"Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, McAllister CJ, Shinaberger CS, Gjertson DW, Greenland S (2005) Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 46:489\u2013500","journal-title":"Am J Kidney Dis"},{"key":"9075_CR58","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ajcn\/81.3.543","volume":"81","author":"K Kalantar-Zadeh","year":"2005","unstructured":"Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB (2005) Survival advantages of obesity in dialysis patients. Am J Clin Nutr 81:543\u2013554","journal-title":"Am J Clin Nutr"},{"key":"9075_CR59","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1053\/j.jrn.2004.09.020","volume":"15","author":"K Kalantar-Zadeh","year":"2005","unstructured":"Kalantar-Zadeh K (2005) Causes and consequences of the reverse epidemiology of body mass index in dialysis patients. J Ren Nutr 15:142\u2013147","journal-title":"J Ren Nutr"},{"key":"9075_CR60","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1001\/archinte.165.15.1797-a","volume":"165","author":"K Kalantar-Zadeh","year":"2005","unstructured":"Kalantar-Zadeh K, Anker SD, Coats AJ, Horwich TB, Fonarow GC (2005) Obesity paradox as a component of reverse epidemiology in heart failure. Arch Intern Med 165:1797","journal-title":"Arch Intern Med"},{"key":"9075_CR61","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1046\/j.1523-1755.2003.00803.x","volume":"63","author":"K Kalantar-Zadeh","year":"2003","unstructured":"Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD (2003) Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63:793\u2013808","journal-title":"Kidney Int"},{"key":"9075_CR62","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1053\/j.ajkd.2005.05.006","volume":"46","author":"K Kalantar-Zadeh","year":"2005","unstructured":"Kalantar-Zadeh K, Miller LG, Daar ES (2005) Diagnostic discordance for hepatitis C virus infection in hemodialysis patients. Am J Kidney Dis 46:\t290\u2013300","journal-title":"Am J Kidney Dis"},{"key":"9075_CR63","doi-asserted-by":"crossref","unstructured":"Miller LG, Kalantar-Zadeh K, Daar ES (2005) Diagnostic discordance for hepatitis C virus infection in hemodialysis: correlations with clinical and laboratory features [Reply to Letter]. Am J Kid Dis DOI: 10.1053\/j.ajkd.2005.07.045. Cited 4 October 2005","DOI":"10.1053\/j.ajkd.2005.07.045"},{"key":"9075_CR64","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cyto.2004.07.007","volume":"28","author":"K Pawlak","year":"2004","unstructured":"Pawlak K, Pawlak D, Mysliwiec M (2004) Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients. Cytokine 28:197\u2013204","journal-title":"Cytokine"},{"key":"9075_CR65","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3748\/wjg.v8.i3.562","volume":"8","author":"RP Woitas","year":"2002","unstructured":"Woitas RP, Petersen U, Moshage D, Brackmann HH, Matz B, Sauerbruch T, Spengler U (2002) HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C. World J Gastroenterol 8:562\u2013566","journal-title":"World J Gastroenterol"},{"key":"9075_CR66","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/sj.gene.6364072","volume":"5","author":"CL Thio","year":"2004","unstructured":"Thio CL, Goedert JJ, Mosbruger T, Vlahov D, Strathdee SA, O\u2019Brien SJ, Astemborski J, Thomas DL (2004) An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection. Genes Immun 5:294\u2013300","journal-title":"Genes Immun"},{"key":"9075_CR67","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1089\/107999099314072","volume":"19","author":"M Radovic","year":"1999","unstructured":"Radovic M, Jelkmann W, Djukanovic L, Ostric V (1999) Serum erythropoietin and interleukin-6 levels in hemodialysis patients with hepatitis virus infection. J Interferon Cytokine Res 19:369\u2013373","journal-title":"J Interferon Cytokine Res"},{"key":"9075_CR68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02936370","volume":"32","author":"M Malaguarnera","year":"1997","unstructured":"Malaguarnera M, Di Fazio I, Romeo MA, Restuccia S, Laurino A, Trovato BA (1997) Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus. J Gastroenterol 32:211\u2013215","journal-title":"J Gastroenterol"},{"key":"9075_CR69","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S1386-6346(03)00200-6","volume":"27","author":"M Kido","year":"2003","unstructured":"Kido M, Kumagai N, Toda K, Tsuchimoto K, Komiyama T (2003) Differential induction of serum interleukin-6 and -12 by interferon-alpha and -beta administration in chronic hepatitis C patients. Hepatol Res 27:101\u2013108","journal-title":"Hepatol Res"},{"key":"9075_CR70","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/ndt\/gfh804","volume":"20","author":"J Borawski","year":"2005","unstructured":"Borawski J, Naumnik B, Mysliwiec M (2005) Liver disease vs systemic inflammation in haemodialysis patients. Nephrol Dial Transplant 20:1277\u20131278","journal-title":"Nephrol Dial Transplant"},{"key":"9075_CR71","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1046\/j.1523-1755.1998.00883.x","volume":"53","author":"BJ Pereira","year":"1998","unstructured":"Pereira BJ, Natov SN, Bouthot BA, Murthy BV, Ruthazer R, Schmid CH, Levey AS (1998) Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The new England organ bank hepatitis C study group. Kidney Int 53:1374\u20131381","journal-title":"Kidney Int"},{"key":"9075_CR72","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1053\/j.ajkd.2003.12.030","volume":"43","author":"M Espinosa","year":"2004","unstructured":"Espinosa M, Martn-Malo A, Ojeda R, Santamara R, Soriano S, Aguera M, Aljama P (2004) Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences. Am J Kidney Dis 43:685\u2013689","journal-title":"Am J Kidney Dis"},{"key":"9075_CR73","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0272-6386(98)70027-7","volume":"32","author":"CO Stehman-Breen","year":"1998","unstructured":"Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ (1998) Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 32:629\u2013634","journal-title":"Am J Kidney Dis"},{"key":"9075_CR74","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1681\/ASN.V11101896","volume":"11","author":"E Nakayama","year":"2000","unstructured":"Nakayama E, Akiba T, Marumo F, Sato C (2000) Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 11:1896\u20131902","journal-title":"J Am Soc Nephrol"},{"key":"9075_CR75","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1093\/ndt\/16.8.1669","volume":"16","author":"M Espinosa","year":"2001","unstructured":"Espinosa M, Martin-Malo A, Alvarez de Lara MA, Aljama P (2001) Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients. Nephrol Dial Transplant 16:1669\u20131674","journal-title":"Nephrol Dial Transplant"},{"key":"9075_CR76","doi-asserted-by":"crossref","first-page":"B1","DOI":"10.1053\/j.ajkd.2005.10.015","volume":"47","author":"K Kalantar-Zadeh","year":"2006","unstructured":"Kalantar-Zadeh K, McAllister CJ, Miller LG, Daar ES, Gjertson DW, Kopple JD, Greenland S, Kilpatrick RD (2006) Hepatitis C virus and death risk in hemodialysis patients. Am J Kid Dis 47:B1\u2013B18 (abstract #73, NKF Spring Clinical Meetings April 19\u201323, 2006, Chicago, IL), 2006 [abstract]","journal-title":"Am J Kid Dis"},{"key":"9075_CR77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/jren.2003.50005","volume":"13","author":"K Kalantar-Zadeh","year":"2003","unstructured":"Kalantar-Zadeh K, Supasyndh O, Lehn RS, McAllister CJ, Kopple JD (2003) Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt\/V greater than 1.20. J Ren Nutr 13:15\u201325","journal-title":"J Ren Nutr"},{"key":"9075_CR78","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/jhep.2002.34613","volume":"36","author":"F Fabrizi","year":"2002","unstructured":"Fabrizi F, Poordad FF, Martin P (2002) Hepatitis C infection and the patient with end-stage renal disease. Hepatology 36:3\u201310","journal-title":"Hepatology"},{"key":"9075_CR79","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ki.1993.354","volume":"44","author":"S Pol","year":"1993","unstructured":"Pol S, Romeo R, Zins B, Driss F, Lebkiri B, Carnot F, Berthelot P, Brechot C (1993) Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int 44:1097\u20131100","journal-title":"Kidney Int"},{"key":"9075_CR80","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/ajkd.2001.25199","volume":"38","author":"S Saab","year":"2001","unstructured":"Saab S, Brezina M, Gitnick G, Martin P, Yee HF Jr (2001) Hepatitis C screening strategies in hemodialysis patients. Am J Kidney Dis 38:91\u201397","journal-title":"Am J Kidney Dis"},{"key":"9075_CR81","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/ajkd.2001.21294","volume":"37","author":"S Saab","year":"2001","unstructured":"Saab S, Martin P, Brezina M, Gitnick G, Yee HF Jr (2001) Serum alanine aminotransferase in hepatitis C screening of patients on hemodialysis. Am J Kidney Dis 37:308\u2013315","journal-title":"Am J Kidney Dis"},{"key":"9075_CR82","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1093\/ndt\/gfh895","volume":"5","author":"K Kalantar-Zadeh","year":"2005","unstructured":"Kalantar-Zadeh K, McAllister CJ, Miller LG (2005) Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study. Nephrol Dial Transplant 5:1662\u20131669","journal-title":"Nephrol Dial Transplant"},{"key":"9075_CR83","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1128\/JCM.40.5.1656-1659.2002","volume":"40","author":"M Abdel-Hamid","year":"2002","unstructured":"Abdel-Hamid M, El-Daly M, El-Kafrawy S, Mikhail N, Strickland GT, Fix AD (2002) Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus. J Clin Microbiol 40:1656\u20131659","journal-title":"J Clin Microbiol"},{"key":"9075_CR84","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0891-5520(05)70177-X","volume":"15","author":"SL Zacks","year":"2001","unstructured":"Zacks SL, Fried MW (2001) Hepatitis B and C and renal failure. Infect Dis Clin North Am 15:877\u2013899","journal-title":"Infect Dis Clin North Am"},{"key":"9075_CR85","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jcv.2003.10.004","volume":"30","author":"N Khan","year":"2004","unstructured":"Khan N, Aswad S, Shidban H, Aghajani M, Mendez R, Comanor L (2004) Improved detection of HCV infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center. J Clin Virol 30:175\u2013182","journal-title":"J Clin Virol"},{"key":"9075_CR86","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1046\/j.1365-2796.2002.00938.x","volume":"251","author":"G Almroth","year":"2002","unstructured":"Almroth G, Ekermo B, Mansson AS, Svensson G, Widell A (2002) Detection and prevention of hepatitis C in dialysis patients and renal transplant recipients. A long-term follow up (1989\u2013January 1997). J Intern Med 251:119\u2013128","journal-title":"J Intern Med"},{"key":"9075_CR87","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/jmv.20122","volume":"73","author":"N Hanuka","year":"2004","unstructured":"Hanuka N, Sikuler E, Tovbin D, Neville L, Nussbaum O, Mostoslavsky M, Orgel M, Yaari A, Manor S, Dagan S, Hilzenrat N, Shemer-Avni Y (2004) Hepatitis C virus infection in dialysis and chronic liver patients: viraemia dependent anti-E2-antibody response. J Med Virol 73:529\u2013535","journal-title":"J Med Virol"},{"key":"9075_CR88","first-page":"213","volume":"72","author":"OK Ndimbie","year":"1996","unstructured":"Ndimbie OK, Kingsley LA, Nedjar S, Rinaldo CR (1996) Hepatitis C virus infection in a male homosexual cohort: risk factor analysis. Genitourin Med 72:213\u2013216","journal-title":"Genitourin Med"},{"key":"9075_CR89","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/hep.1840170103","volume":"17","author":"TM Chan","year":"1993","unstructured":"Chan TM, Lok AS, Cheng IK, Chan RT (1993) Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology 17:5\u20138","journal-title":"Hepatology"},{"key":"9075_CR90","first-page":"1","volume":"52","author":"MJ Alter","year":"2003","unstructured":"Alter MJ, Kuhnert WL, Finelli L (2003) Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for disease control and prevention. MMWR recomm rep 52:1\u201313, 15; quiz CE11\u201314","journal-title":"MMWR recomm rep"},{"key":"9075_CR91","first-page":"73","volume":"92","author":"F Umlauft","year":"1997","unstructured":"Umlauft F, Gruenewald K, Weiss G, Kessler H, Urbanek M, Haun M, Santner B, Koenig P, Keeffe EB (1997) Patterns of hepatitis C viremia in patients receiving hemodialysis. Am J Gastroenterol 92:73\u201378","journal-title":"Am J Gastroenterol"},{"key":"9075_CR92","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/ajkd.2001.20630","volume":"37","author":"E Noiri","year":"2001","unstructured":"Noiri E, Nakao A, Oya A, Fujita T, Kimura S (2001) Hepatitis C virus in blood and dialysate in hemodialysis. Am J Kidney Dis 37:38\u201342","journal-title":"Am J Kidney Dis"},{"key":"9075_CR93","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1111\/j.1572-0241.2001.04669.x","volume":"96","author":"L Comanor","year":"2001","unstructured":"Comanor L, Anderson F, Ghany M, Perrillo R, Heathcote EJ, Sherlock C, Zitron I, Hendricks D, Gordon SC (2001) Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment. Am J Gastroenterol 96:2968\u20132972","journal-title":"Am J Gastroenterol"},{"key":"9075_CR94","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1128\/JCM.41.1.310-317.2003","volume":"41","author":"G Gorrin","year":"2003","unstructured":"Gorrin G, Friesenhahn M, Lin P, Sanders M, Pollner R, Eguchi B, Pham J, Roma G, Spidle J, Nicol S, Wong C, Bhade S, Comanor L (2003) Performance evaluation of the VERSANT HCV RNA qualitative assay by using transcription-mediated amplification. J\u2423Clin Microbiol 41:310\u2013317","journal-title":"J Clin Microbiol"},{"key":"9075_CR95","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1128\/JCM.41.2.651-656.2003","volume":"41","author":"DA Hendricks","year":"2003","unstructured":"Hendricks DA, Friesenhahn M, Tanimoto L, Goergen B, Dodge D, Comanor L (2003) Multicenter evaluation of the VERSANT HCV RNA qualitative assay for detection of hepatitis C virus RNA. J Clin Microbiol 41:651\u2013656","journal-title":"J Clin Microbiol"},{"key":"9075_CR96","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1053\/jhep.2000.17709","volume":"32","author":"C Sarrazin","year":"2000","unstructured":"Sarrazin C, Teuber G, Kokka R, Rabenau H, Zeuzem S (2000) Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays. Hepatology 32:818\u2013823","journal-title":"Hepatology"},{"key":"9075_CR97","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1128\/JCM.40.8.2903-2907.2002","volume":"40","author":"M Krajden","year":"2002","unstructured":"Krajden M, Ziermann R, Khan A, Mak A, Leung K, Hendricks D, Comanor L (2002) Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay. J Clin Microbiol 40:2903\u20132907","journal-title":"J Clin Microbiol"},{"key":"9075_CR98","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S1386-6532(02)00234-2","volume":"28","author":"L Comanor","year":"2003","unstructured":"Comanor L, Elkin C, Leung K, Krajden M, Kronquist K, Nicolas K, Horansky E, deMedina M, Kittichai P, Sablon E, Ziermann R, Sherlock C (2003) Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay. J Clin Virol 28:14\u201326","journal-title":"J Clin Virol"},{"key":"9075_CR99","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jcv.2005.05.007","volume":"34","author":"EI Rigopoulou","year":"2005","unstructured":"Rigopoulou EI, Stefanidis I, Liaskos C, Zervou EK, Rizos C, Mina P, Zachou K, Syrganis C, Patsidis E, Kyriakopoulos G, Sdrakas L, Tsianas N, Dalekos GN (2005) HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: results from five hemodialysis units in central Greece. J Clin Virol 34:81\u201385","journal-title":"J Clin Virol"},{"key":"9075_CR100","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cld.2005.05.006","volume":"9","author":"F Fabrizi","year":"2005","unstructured":"Fabrizi F, Bunnapradist S, Martin P (2005) Treatment of hepatitis C in potential kidney and heart transplant patients. Clin Liver Dis 9:487\u2013503, viii","journal-title":"Clin Liver Dis"},{"key":"9075_CR101","first-page":"249","volume":"56","author":"F Fabrizi","year":"2004","unstructured":"Fabrizi F, Bunnapradist S, Lunghi G, Aucella F, Martin P (2004) Epidemiology and clinical significance of hepatotropic infections in dialysis patients. Recent evidence. Minerva Urol Nefrol 56:249\u2013257","journal-title":"Recent evidence. Minerva Urol Nefrol"},{"key":"9075_CR102","first-page":"165","volume":"50","author":"H Sakugawa","year":"2003","unstructured":"Sakugawa H, Nakasone H, Nakayoshi T, Kawakami Y, Yamashiro T, Maeshiro T, Kinjo F, Saito A, Yakabi S (2003) Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT. Hepatogastroenterology 50:165\u2013169","journal-title":"Hepatogastroenterology"},{"key":"9075_CR103","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/j.1572-0241.2003.07526.x","volume":"98","author":"MW Russo","year":"2003","unstructured":"Russo MW, Goldsweig CD, Jacobson IM, Brown RS Jr (2003) Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety. Am J Gastroenterol 98:1610\u20131615","journal-title":"Am J Gastroenterol"},{"key":"9075_CR104","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1097\/01.ASN.0000079613.81511.3C","volume":"14","author":"N Kamar","year":"2003","unstructured":"Kamar N, Toupance O, Buchler M, Sandres-Saune K, Izopet J, Durand D, Rostaing L (2003) Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation. J Am Soc Nephrol 14:2092\u20132098","journal-title":"J Am Soc Nephrol"},{"key":"9075_CR105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/039139880302600502","volume":"26","author":"F Fabrizi","year":"2003","unstructured":"Fabrizi F, Bunnapradist S, Aucella F, Lunghi G, Martin P (2003) Treatment of HCV-related liver diseases after renal transplantation: modern views. Int J Artif Organs 26:373\u2013382","journal-title":"Int J Artif Organs"},{"key":"9075_CR106","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1086\/517339","volume":"176","author":"J Izopet","year":"1997","unstructured":"Izopet J, Rostaing L, Moussion F, Alric L, Dubois M, That HT, Payen JL, Duffaut M, Durand D, Suc JM, Puel J (1997) High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy. J Infect Dis 176:1614\u20131617","journal-title":"J Infect Dis"},{"key":"9075_CR107","unstructured":"Natov SN, Pereira BJ (2005) Hepatitis C virus infection in patients on maintenance dialysis, in UpToDate (since Oct 2005), edited by Rose B, Wellesley, MA, UpToDate, Inc"},{"key":"9075_CR108","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.transproceed.2004.07.025","volume":"36","author":"DH Mousa","year":"2004","unstructured":"Mousa DH, Abdalla AH, Al-Shoail G, Al-Sulaiman MH, Al-Hawas FA, Al-Khader AA (2004) Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C. Transplant Proc 36:1831\u20131834","journal-title":"Transplant Proc"},{"key":"9075_CR109","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1097\/01.TP.0000158279.29506.E0","volume":"79","author":"N Kamar","year":"2005","unstructured":"Kamar N, Izopet J, Alric L, Rostaing L (2005) Lack of evidence for ribavirin monotherapy efficacy on liver fibrosis in hepatitis C virus positive renal transplant patients. Transplantation 79:1770\u20131771, author reply 1771, 2005","journal-title":"Transplantation"},{"key":"9075_CR110","unstructured":"Center for disease control and prevention (2001) Recommendations and reports: recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR 50(RR05) 1\u201343. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5005 5001.htm, 2001"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-006-9075-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-006-9075-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-006-9075-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-006-9075-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T19:56:29Z","timestamp":1652817389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-006-9075-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,29]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["9075"],"URL":"https:\/\/doi.org\/10.1007\/s11255-006-9075-8","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,29]]},"assertion":[{"value":"8 March 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"247"}}